Skip to content

DR. PETER VANACKER

Active
Private limited companyfounded 2019active for 7 yearsIsabella Brantstraat 42, 2018 Antwerpen, BelgiumKBO/BCE: BE 0735.599.894
Summary

DR. PETER VANACKER has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €6,523 and a net result of €284,895. Equity is growing by about 9.2% per year across the filed financial years. Its solvency ranks better than 5% of 291 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
2 sites
Size
€436,803total assets 2026
Equity
€6,523
Profit
€284,895
Turnover not published (micro format)
Financial health
90 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2026 accounts 104 days early2 of 3 deeds summarised
Why 90raises riskEquity €6,523 (1.5% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €436,803Figures for financial year 2026 (filed 19-07-2026)Show the evidence

Checked score

Score 2026
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 23% of its sector peers (NACE 86, micro)
Financial strength · tick = 2025
Average
Solvency 26-64
equity 1.5% of total assets
Liquidity 20-30
short-term debt 94.4% · cash 16.2%
Profitability 100=
return on assets 65.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.3%▲ +0.1 percentage points vs 09-2025highest value 11-2025: 0.1%▼ -0.2 percentage points vs 10-2025 12-2025: < 0.1%▼ -0.1 percentage points vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €500 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.69, compared with 2.62 in 2025, below 1; short-term debt: 94.4% and cash: 16.2% of total assets), and 98.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 6% on solvency, 3% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €436,803
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €6,523 (1.5% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2026 (filed 19-07-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 291 sector peers (2026).
NBB · sector comparison
Position among 291 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 19-07-2026, 104 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2026
104 days early
2025
2 days early
2024
1 day early
2023
on the day
2022
3 days early
2021
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 19 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 29 October (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Highest result from 2021 to 2026net €284,895 ▲2.2%
  3. Annual accounts filedfinancial year 2025 · micro…

Financials · financial year 2026, micro format

Equity
€6,523▼ 98.9%
2025 · €581,428
Total assets
€436,803▼ 51.4%
2025 · €898,661
Net result
€284,895▲ 2.2%
2025 · €278,639
Working capital
-€126,099
2025 · €438,973
Trend over the years

2022 to 2026, 5 financial years 2021 to 2026, 6 financial years

The operating result has risen four years in a row; 2026 is 2% above 2025 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€349,633 2026 Net result€284,895 2026

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202120222023202420252026
Operating result€387,351-€189,341▼ 51.1%€206,462▲ 9.0%€238,660▲ 15.6%€342,229▲ 43.4%€349,633▲ 2.2%
Net result€276,163above the sector's middle half-€142,317above the sector's middle half▼ 48.5%€160,418above the sector's middle half▲ 12.7%€180,491above the sector's middle half▲ 12.5%€278,639above the sector's middle half▲ 54.4%€284,895▲ 2.2%
Equity€280,363within the sector's middle half-€421,880above the sector's middle half▲ 50.5%€582,298above the sector's middle half▲ 38.0%€502,789above the sector's middle half▼ 13.7%€581,428above the sector's middle half▲ 15.6%€6,523▼ 98.9%
Total assets€733,894above the sector's middle half-€718,421above the sector's middle half▼ 2.1%€854,563above the sector's middle half▲ 19.0%€892,445above the sector's middle half▲ 4.4%€898,661above the sector's middle half▲ 0.7%€436,803▼ 51.4%
Debt€453,532-€296,541▼ 34.6%€272,265▼ 8.2%€389,656▲ 43.1%€317,233▼ 18.6%€430,280▲ 35.6%
Working capital€223,193within the sector's middle half-€380,540above the sector's middle half▲ 70.5%€505,678above the sector's middle half▲ 32.9%€386,048above the sector's middle half▼ 23.7%€438,973above the sector's middle half▲ 13.7%-€126,099
Solvency38.2%within the sector's middle half-58.7%within the sector's middle half▲ 20.5pp68.1%within the sector's middle half▲ 9.4pp56.3%within the sector's middle half▼ 11.8pp64.7%within the sector's middle half▲ 8.4pp1.5%▼ 63.2pp
Current ratio2.11within the sector's middle half-7.11above the sector's middle half▲ 5.005.88within the sector's middle half▼ 1.232.31within the sector's middle half▼ 3.572.62within the sector's middle half▲ 0.310.69▼ 1.92
Return on assets (ROA)37.6%above the sector's middle half-19.8%within the sector's middle half▼ 17.8pp18.8%within the sector's middle half▼ 1.0pp20.2%within the sector's middle half▲ 1.5pp31.0%within the sector's middle half▲ 10.8pp65.2%▲ 34.2pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2026 in colour, 2025 as the grey bar beneath
Assets €436,803
Fixed assets €150,438 ▼ 20.2%
Current assets €286,366 ▼ 59.7%
Equity and liabilities €436,803
Equity €6,523 ▼ 98.9%
Debt €430,280 ▲ 35.6%
Debt's share of the balance-sheet total rises from 35.3% to 98.5%. Equity is lower and debt is higher.
Key figures and ratios
2026 value · change against 2025
EBITDA
€393,122▲
2025 · €383,872
Cash flow
€328,385▲
2025 · €320,283
Debt to equity
65.96▲
2025 · 0.55
Interest coverage
over 100
2025 · over 100
Debt ≤ 1 year
€412,465▲
2025 · €271,209
Debt > 1 year
€0▼
2025 · €34,285
Income taxes
€88,450▲
2025 · €87,364
A ratio outside any meaningful range has been withheld (balance sheet total €436,803, equity €6,523).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,153 companies that looked in July 2024 the way this one looks now, 1.7% went bankrupt within 24 months and 96.1% are still going.

  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
1.7% went bankrupt
2.2% stopped otherwise
96.1% still going

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,153 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2026 against 2025 · 49 lines
Balance sheet Code20252026
Assets
Total assets20/58€898,661€436,803▼
Formation expenses20€0-
Fixed assets21/28€188,479€150,438▼
Intangible fixed assets21€157,500€122,500▼
Tangible fixed assets22/27€30,979€27,938▼
Plant, machinery and equipment23€15,369€13,975▼
Furniture and vehicles24€9,110€8,556▼
Other tangible fixed assets26€6,500€5,406▼
Current assets29/58€710,182€286,366▼
Amounts receivable within one year40/41€43,170€0▼
Other amounts receivable41€43,170€0▼
Current investments50/53€385,162€50,000▼
Cash at bank and in hand54/58€87,466€70,731▼
Deferred charges and accrued income490/1€194,384€165,635▼
Equity and liabilities
Total equity and liabilities10/49€898,661€436,803▼
Equity10/15€581,428€6,523▼
Contributions10/11€5,000€5,000=
Reserves13€576,428€1,523▼
Distributable reserves133€576,428€1,523▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€317,233€430,280▲
Amounts payable after more than one year17€34,285€0▼
Financial debts170/4€34,285€0▼
Amounts payable within one year42/48€271,209€412,465▲
Current portion of amounts payable after more than one year42€51,046€34,285▼
Trade debts44€3,104€1,702▼
Suppliers440/4€3,104€1,702▼
Taxes, remuneration and social security45€47,060€50,755▲
Taxes450/3€47,060€50,755▲
Other amounts payable47/48€170,000€325,723▲
Accrued charges and deferred income492/3€11,738€17,815▲
Income statement Code20252026
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€41,643€43,489▲
Other operating charges640/8€1,567€1,278▼
Gross operating margin9900€385,439€394,400▲
Operating profit (loss)9901€342,229€349,633▲
Financial income75/76B€25,010€24,380▼
Recurring financial income75€25,010€24,380▼
Financial charges65/66B€1,235€667▼
Recurring financial charges65€1,235€667▼
Profit (loss) for the period before taxes9903€366,003€373,345▲
Income taxes67/77€87,364€88,450▲
Profit (loss) for the period9904€278,639€284,895▲
Profit (loss) for the period to be appropriated9905€278,639€284,895▲
Appropriation of the result
Profit (loss) to be appropriated9906€278,639€284,895▲
Transfer from equity791/2€0€575,000▲
Transfer to equity691/2€78,639€95▼
To other reserves6921€78,639€95▼
Profit to be distributed694/7€200,000€859,800▲
Return on contributions (dividend)694€200,000€859,800▲

The notes to these accounts (17 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202120222023202420252026Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€57,681€38,894€40,033€40,411€41,643€43,489▲ 4.4%
Other operating charges640/8-€212€214€224€1,567€1,278▼ 18.5%
Gross operating margin9900€450,241€228,447€246,708€279,295€385,439€394,400▲ 2.3%
Operating profit (loss)9901€387,351€189,341€206,462€238,660€342,229€349,633▲ 2.2%
Financial income75/76B-€1,002€5,824€510€25,010€24,380▼ 2.5%
Recurring financial income75€237€1,002€5,824€510€25,010€24,380▼ 2.5%
Financial charges65/66B-€3,627€2,256€1,747€1,235€667▼ 46.0%
Recurring financial charges65€5,241€3,524€2,256€1,747€1,235€667▼ 46.0%
Non-recurring financial charges66B-€103€0----
Profit (loss) for the period before taxes9903€382,346€186,716€210,030€237,423€366,003€373,345▲ 2.0%
Income taxes67/77€106,184€44,398€49,613€56,932€87,364€88,450▲ 1.2%
Profit (loss) for the period9904€276,163€142,317€160,418€180,491€278,639€284,895▲ 2.2%
Profit (loss) for the period to be appropriated9905€276,163€142,317€160,418€180,491€278,639€284,895▲ 2.2%
Line202120222023202420252026Change
Assets
Total assets20/58€733,894€718,421€854,563€892,445€898,661€436,803▼ 51.4%
Formation expenses20€1,832€1,308€785€262€0--
Fixed assets21/28€308,249€274,290€244,482€210,494€188,479€150,438▼ 20.2%
Intangible fixed assets21€297,500€262,500€227,500€192,500€157,500€122,500▼ 22.2%
Tangible fixed assets22/27€10,239€11,790€16,982€17,994€30,979€27,938▼ 9.8%
Plant, machinery and equipment23-€5,442€7,322€10,549€15,369€13,975▼ 9.1%
Furniture and vehicles24-€6,349€9,660€7,445€9,110€8,556▼ 6.1%
Other tangible fixed assets26----€6,500€5,406▼ 16.8%
Financial fixed assets28€510------
Current assets29/58€423,814€442,823€609,296€681,689€710,182€286,366▼ 59.7%
Amounts receivable within one year40/41--€19,448€33,430€43,170€0▼ 100%
Other amounts receivable41--€19,448€33,430€43,170€0▼ 100%
Current investments50/53€30,090€71,675€320,092€413,458€385,162€50,000▼ 87.0%
Cash at bank and in hand54/58€227,844€173,243€91,553€57,834€87,466€70,731▼ 19.1%
Deferred charges and accrued income490/1-€197,905€178,202€176,967€194,384€165,635▼ 14.8%
Equity and liabilities
Total equity and liabilities10/49€733,894€718,421€854,563€892,445€898,661€436,803▼ 51.4%
Equity10/15€280,363€421,880€582,298€502,789€581,428€6,523▼ 98.9%
Contributions10/11-€5,000€5,000€5,000€5,000€5,000=
Reserves13€275,363€416,880€577,298€497,789€576,428€1,523▼ 99.7%
Distributable reserves133-€416,880€577,298€497,789€576,428€1,523▼ 99.7%
Profit (loss) carried forward14--€0€0€0€0-
Amounts payable17/49€453,532€296,541€272,265€389,656€317,233€430,280▲ 35.6%
Amounts payable after more than one year17€235,754€186,060€135,923€85,331€34,285€0▼ 100%
Financial debts170/4-€186,060€135,923€85,331€34,285€0▼ 100%
Amounts payable within one year42/48€200,621€62,283€103,617€295,641€271,209€412,465▲ 52.1%
Current portion of amounts payable after more than one year42-€49,694€50,137€50,591€51,046€34,285▼ 32.8%
Trade debts44€6,801€1,524€4,914€8,870€3,104€1,702▼ 45.2%
Suppliers440/4-€1,524€4,914€8,870€3,104€1,702▼ 45.2%
Taxes, remuneration and social security45-€9,571€48,565€28,779€47,060€50,755▲ 7.9%
Taxes450/3-€9,571€48,565€28,779€47,060€50,755▲ 7.9%
Other amounts payable47/48-€1,494€0€207,400€170,000€325,723▲ 91.6%
Accrued charges and deferred income492/3-€48,199€32,725€8,684€11,738€17,815▲ 51.8%
Line202120222023202420252026Change
Profit (loss) for the period9904€276,163€142,317€160,418€180,491€278,639€284,895▲ 2.2%
+ Depreciation and write-downs630€57,681€38,894€40,033€40,411€41,643€43,489▲ 4.4%
Operating cash flow (approximation)€333,844€181,211€200,450€220,902€320,283€328,385▲ 2.5%
Investment in fixed assets (approximation)--€4,935-€10,225-€6,423-€19,628-€5,448▲ 72.2%
Change in cash--€54,601-€81,690-€33,719€29,632-€16,735-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (6)
Financial year Type Filed Reference
31-03-2026 micro format 19-07-2026 2026-00324443
31-03-2025 micro format 29-10-2025 2025-00555186
31-03-2024 micro format 30-10-2024 2024-00521165
31-03-2023 micro format 31-10-2023 2023-00500545
31-03-2022 micro format 28-10-2022 2022-20485283
31-03-2021 micro format 29-10-2021 2021-75200045

Similar companies · same sector, comparable size

Of the 16,582 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,113. 1,817 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 2 of 3 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

DR. PETER VANACKER was incorporated on 2 October 2019 as a private limited company.1 The registered office was moved to Antwerpen in 2023.2 Total assets fell from €733,894 in 2021 to €436,803 in 2026.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 06-11-2023
  3. 3National Bank, annual accounts 2021 and 2026

Acts, filings and financial milestones

Next filing, financial year 2027, expected by 31-10-2027
2026
19-07
NBB filing Annual accounts filed
financial year 2026 · micro format
31-03
Financial Highest result from 2021 to 2026net €284,895 ▲2.2%
Net result €284,895, the highest in the series.
2025
29-10
NBB filing Annual accounts filed
financial year 2025 · micro format
2024
30-10
NBB filing Annual accounts filed
financial year 2024 · micro format
2023
22-11
Gazette deed Miscellaneous
Registered-office move2 facts ▸
  • Board meeting, 29-09-2023
  • Registered-office move, Isabella Brantstraat 42, 2018 Antwerpen
06-11
Gazette deed Registered office
Registered-office move2 facts ▸
  • General meeting, 22-08-2023
  • Registered-office move, Isabella Brantstraat 42 te 2018 Antwerpen
31-10
NBB filing Annual accounts filed
financial year 2023 · micro format
31-03
Financial Equity above €500,000equity €582,298 ▲38%
A profit in every financial year since 2021 builds equity to €582,298.
2022
28-10
NBB filing Annual accounts filed
financial year 2022 · micro format
31-03
Financial Weakest financial yearnet €142,317 ▼48.5%
Net result drops to €142,317, the lowest in the series; recovery starts the following year.
31-03
Financial Liquidity more than triplescurrent ratio 7.11
Current ratio from 2.11 to 7.11; short-term debt falls from €200,621 to €62,283.
2021
29-10
NBB filing Annual accounts filed
financial year 2021 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 3 deeds read
About the unread acts

Of the 3 Belgian Official Gazette deeds we know for this company, 2 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded02-10-2019
Financial year end31-03
Activities, NACEBEL 2025
86220Specialist medical practice
72109Other research and development on natural sciences
86995Nutrition and dietetics services
94120Activities of professional membership organisations
E-invoicing
Reachable via Peppol
Peppol ID 0208:0735599894
Registered 27-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 25 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Antwerpen · 2 establishment units since 2019
registered office establishment All 2 establishment units on the map
Ground area
17.1 ha
Building footprint
6.1 ha
Building volume
1,687 m³
3 parcels, Flanders · tallest building 18.1 m. Linked by address, not a title deed.
2 establishment units
DR. PETER VANACKER
President Kennedylaan(Kor) 4, 8500 KortrijkSpecialist medical practice
since 2019unit no. 2.294.838.173
DR. PETER VANACKER
Wilrijkstraat 10, 2650 EdegemSpecialist medical practice
since 2019unit no. 2.294.838.272
3 parcels
Flanders 3 (100%)
Cadastral parcel Region Area Buildings Height / floors
34026A0631/00H000 Flanders 13.7 ha 1 · 3.4 ha -
11472C0079/00E000 Flanders 3.4 ha 1 · 2.7 ha -
11810K1533/00L004 Flanders 236 m² 1 · 139 m² 18.1 m · 5
How the parcels are linked
Good to know
All 3 parcels match the address exactly.